For this pathway, the COR approval must be within the last 12 months, for the same medicine and manufacturing conditions
Directtoconsumer (cashpay) options: Manufacturers Eli Lilly and Novo Nordisk now offer programs that allow patients to buy GLP1s without insurance at reduced cash prices
Results vary from person to person and depend on medical history, consistency, dose progression, nutrition, and lifestyle factors.
The decision to escalate to maximum dose should be made carefully between you and your provider, weighing results achieved at lower doses against the increased side effect burden
In further embodiments, the auris formulation or composition contains a viscosity enhancing agent or viscosity modulating agent sufficient to provide a viscosity of about 2 cP to about 250,000 cP, about 2 cP to about 100,000 cP, about 2 cP to about 50,000 cP, about 2 cP to about 25,000 cP, about 2 cP to about 10,000 cP, about 2 cP to about 5,000 cP, about 2 cP to about 1,000 cP, about 2 cP to about 500 cP, about 2 cP to about 250 cP, about 2 cP to about 100 cP, about 2 cP to about 90 cP, about 2 cP to about 80 cP, about 2 cP to about 70 cP, about 2 cP to about 60 cP, about 2 cP to about 50 cP, about 2 cP to about 40 cP, about 2 cP to about 30 cP, about 2 cP to about 20 cP, or about 2 cP to about 10 cP
Express Scripts serves more than 100 million Americans as a pharmacy benefit manager (PBM)